Day: March 5, 2024

The combination creates the industry’s first cost effective and holistic view of occupancy on both a strategic and operational level DALLAS and ZURICH, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) — Tango, a leading provider of cloud-based real estate and facilities management software, today announced it has acquired Locatee, a leading workplace analytics solution. Locatee empowers organizations to make fact-based decisions by providing a complete picture of occupancy, driving strategic portfolio decisions, improving operational space utilization, and increasing employee satisfaction. Financial terms of the private transaction were not disclosed. “The complexities of managing a hybrid workplace mean that organizations are facing an imbalance in space supply and demand, with space utilization rates under 40% on average,” said Pranav...

TORONTO, March 05, 2024 (GLOBE NEWSWIRE) — Vencora today announced that it has acquired SERIVA Inc. (“SERIVA”), through one of Vencora’s companies, Fisa Group. Founded in 2001, SERIVA provides end-to-end treasury management software for financial institutions in Latin America. Its signature platform, Seriva.net, is an integrated software solution focused on the administration of treasury, investment, foreign exchange and financial derivatives products. The company is headquartered in Quito, Ecuador. “Wishing a very warm welcome to SERIVA and its team to Vencora,” said Ateet Patel, Banking Portfolio Manager at Vencora. “SERIVA boosts Vencora’s presence within Latin America and greatly complements our portfolio’s existing banking solutions within the region. We look forward to supporting and propelling the company’s long-term growth.” “We’re...

The acquisition extends Cycode’s portfolio in Application Security Testing (AST) as it surpasses 350% in revenue growth with the biggest bookings quarter in the company’s historyCycode Adds Exclamation Point to Its Complete ASPM Platform with Strategic Acquisition of Bearer, AI-Powered SAST & API Discovery CompanyCycode was founded in 2019 by co-founders (left to right) Dor Atias, VP of R&D, Lior Levy, CEO and Ronen Slavin, CTO.SAN FRANCISCO, March 05, 2024 (GLOBE NEWSWIRE) — In a strategic move that marks a significant leap forward in the industry, Cycode, the leader in Application Security Posture Management (ASPM) with the only complete approach to ASPM, announced the acquisition of Bearer, a modern AI-powered SAST, API discovery and data leak protection that delivers all three solutions in one to help Cycode...

BOSTON and PLEASANTON, Calif., March 05, 2024 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, and Peak Bio Inc. (OTC: PKBO), a clinical-stage biopharmaceutical company focused on developing therapeutics in areas of inflammation and oncology announce a definitive agreement to merge as equals in an all-stock transaction. The combined entity will operate as Akari Therapeutics, Plc, which is expected to continue to be listed and trade on the Nasdaq Capital Market as AKTX. Following closing, the company will have an expanded pipeline that contains multiple compelling assets spanning early and late development stages. An assessment of the pipeline is planned, including program prioritization, updated timelines, near-term...

LAS VEGAS, March 05, 2024 (GLOBE NEWSWIRE) — SensaSure Technologies, Inc. (OTCQB: SSTC) (“SensaSure”) and Verde Bio Holdings, Inc. (OTC: VBHI) (“Verde” or the “Company”), a growing oil and gas company with a focus on the acquisition and management of oil and gas minerals and royalties, today announced the filing of a Registration Statement on Form S-4 (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”) in connection with the previously announced merger between the Company and wholly owned subsidiary of SensaSure (the “Merger”). Verde and SensaSure are working to close the Merger as soon as possible following the satisfaction of all closing conditions, which will create a new OTCQB-listed company focused on the acquisition and management of oil and gas minerals and royalties. “The...

BOSTON and PLEASANTON, Calif., March 05, 2024 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, and Peak Bio Inc. (OTC: PKBO), a clinical-stage biopharmaceutical company focused on developing therapeutics in areas of inflammation and oncology announce a definitive agreement to merge as equals in an all-stock transaction. The combined entity will operate as Akari Therapeutics, Plc, which is expected to continue to be listed and trade on the Nasdaq Capital Market as AKTX. Following closing, the company will have an expanded pipeline that contains multiple compelling assets spanning early and late development stages. An assessment of the pipeline is planned, including program prioritization, updated timelines, near-term...